Filing Manager
Weinstein Benjamin
Reporting Manager
Weinstein Benjamin
Symbol
GLYC
Disclosed Ownership
50,000 shares
Ownership
0.1%
Form type
SCHEDULE 13G/A
Filing time
04 Nov 2024, 14:01:21 UTC
Date of event
30 Oct 2024

Sponsored

Quoteable Key Fact

"Weinstein Benjamin disclosed 0.1% ownership in GLYCOMIMETICS INC Common Stock, $0.001 par value (GLYC) on 30 Oct 2024."

Quick Takeaways

  • Weinstein Benjamin filed SCHEDULE 13G/A for GLYCOMIMETICS INC Common Stock, $0.001 par value (GLYC).
  • Disclosed ownership: 0.1%.
  • Date of event: 30 Oct 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 04 Nov 2024, 14:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Weinstein Benjamin 0.1% 50,000 50,000 0 Benjamin Weinstein Individual